Clinical Trials
|
Font Size |
|
CRMD’s research program is one of the largest in the country for a community-based practice and rivals those of some of the largest academic medical centers. Through clinical trials, Dr. Tolentino is devoted to the development of treatments for retinal diseases like Age-Related Macular Degeneration, Drusen, Diabetic Macular Edema and Retinal Vein Occlusions. CRMD’s certified research staff works closely with bioscience companies, pharmaceutical corporations and the federal government, in order to advance procedures and treatments for the diseases that affect our patients. These innovative treatments, generated by advanced technology, allow the Center for Retina and Macular Disease to potentially offer new options to our patients long before they are accessible to the public.
For more information regarding participation in a clinical research trials, please contact our office at 863/297-5400 to set up an appointment with a physician for an evaluation. Patients who then qualify for a clinical trial are offered cutting-edge technology at no cost.
For an extensive list of our previous clinical trials, click here.
Listed below are the clinical trials that are currently enrolling or will begin enrolling soon at CRMD:
Wet Age-Related Macular Degeneration
GSK - Protocol Number: MD7110852Geographic Atrophy
Pfizer - Protocol Number: B1181002Diabetic Macular Edema
Investigator Sponsored (PRESERVE)Non-Arteritic Anterior Ischemic Optic Neuropathy
Bayer - Protocol Number: 12912